Rankings
▼
Calendar
ZYME Q3 2023 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena
ZYME
Zymeworks Inc.
$2B
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$17M
+527.4% YoY
Gross Profit
$17M
100.0% margin
Operating Income
-$33M
-201.4% margin
Net Income
-$29M
-173.8% margin
EPS (Diluted)
$-0.41
QoQ Revenue Growth
+135.7%
Cash Flow
Operating Cash Flow
-$43M
Free Cash Flow
-$44M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$556M
Total Liabilities
$132M
Stockholders' Equity
$424M
Cash & Equivalents
$94M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$17M
$3M
+527.4%
Gross Profit
$17M
-$34M
+147.9%
Operating Income
-$33M
-$50M
+34.0%
Net Income
-$29M
-$48M
+40.0%
Revenue Segments
Research Support Payments And Other Service
$10M
100%
← FY 2023
All Quarters
Q4 2023 →